Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Noonan Syndrome × sotorasib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 2 Thoracic Neoplasms 1 Noonan Syndrome 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms 1 Neoplasm Metastasis 1 Healthy Participants 1 Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1 Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation 1

Interventions

sotorasib 1 osimertinib 1 nazartinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04959981 2023-07-25

HERKULES-2

Erasca, Inc.

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Noonan Syndrome, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡